Caricamento...

MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review

The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, survival benefit of MET inhibitors remains controversial. We performed this meta-analysis to evaluate the survival benefit of MET inhibitors combined with an epidermal growth factor receptor tyrosine kinase inh...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Kim, Jung Han, Kim, Hyeong Su, Kim, Bum Jun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650440/
https://ncbi.nlm.nih.gov/pubmed/29088885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20824
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !